Thousands of Australians unwittingly contracted HIV and hepatitis C before donated blood was routinely tested. Could a new Senate inquiry mean fairer compensation?
- Associate Professor, Public Health Ethics, School of Population Health, UNSW
You might expect a sexual partner to disclose a sexually transmitted infection. But you can’t rely on this – and criminalising the spread doesn’t work.
Is the cost of research aimed at curing HIV worth it, when HIV can be effectively managed and prevented by existing drugs?
In the future, risk-assessments for whole blood won’t be based on sexual orientation.
Funding announced in this week’s federal budget moves Australia closer to eliminating HIV.
Instead of making the lives of contact tracers easier, analysis shows the expensive technology missed contacts and added to their workload.
Emotive claims, like COVID vaccination being unethical or coercive, are more likely to be shared on social media. But we can fight back.
Clear messaging about who needs to get tested is better than stigmatising people who are understandably worried about their health.
There are some very good reasons why some people decline coronavirus testing, which we need to address before jumping to conclusions.
An increase in condomless sex in PrEP users is predictable as preventing HIV is the key motivator for condom use among gay and bisexual men.
Curing HIV – or at least achieving long-term remission – is possible, under the right circumstances.
Just how much disclosure is it reasonable to expect from a sex partner, particularly if that relationship isn’t a serious and committed one?
A pill a day can prevent HIV, but there’s no guarantee Australians will get access to this intervention anytime soon.
Despite health promotion campaigns and a concerted effort to make antiretroviral therapy more accessible, the number of new HIV cases in Australia has remained stable over the last three years.
Starting HIV treatment early, before immune damage occurs, brings real clinical benefits, a new study has shown.
Australian biotech company Starpharma has announced the imminent launch of a condom coated with an antimicrobial chemical known as VivaGel. While it might be marketed as a great leap forward for preventing…
Australia had a quick and effective response to HIV at the start of the epidemic. Some 30 years later, however, there’s a tendency to underestimate the sheer effort involved in maintaining HIV prevention…
Contact Bridget for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Website
- Article Feed
- ORCID
- Joined
